Inhibition of Bcl-xL expression sensitizes normal human keratinocytes and epithelial cells to apoptotic stimuli

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Oncogene

• Publication date

  1999-08-05

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.onc.1202836PMID 10442640
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Biochemical and molecular mechanisms regulating apoptosis

  2004cited by this paper
• The Role of Antiapoptotic Bcl-2 Family Members in Endothelial Apoptosis Elucidated with Antisense Oligonucleotides*

  1999cited by this paper
• Rapid activation of JNK1 in UV-B irradiated epidermal keratinocytes

  1998cited by this paper
• The Bcl-2 protein family: arbiters of cell survival.

  1998cited by this paper
• Bcl-2-independent Bcr–Abl-mediated resistance to apoptosis: protection is correlated with up regulation of Bcl-xL

  1998cited by this paper
• EGF receptor signaling inhibits keratinocyte apoptosis: evidence for mediation by Bcl-XL

  1998cited by this paper
• Inhibition of neointimal cell bcl-x expression induces apoptosis and regression of vascular disease

  1998cited by this paper
• p53-regulated apoptosis is differentiation dependent in ultraviolet B-irradiated mouse keratinocytes.

  1998cited by this paper
• Bcl-xL modulates apoptosis induced by anticancer drugs and delays DEVDase and DNA fragmentation-promoting activities.

  1998cited by this paper
• A Bcl-xL transgene promotes malignant conversion of chemically initiated skin papillomas.

  1998influential reference
• TNF Receptor Death Domain-associated Proteins TRADD and FADD Signal Activation of Acid Sphingomyelinase*

  1998cited by this paper
• Expression of bcl-2 and bcl-X in bladder cancer.

  1998cited by this paper
• [Chromosome translocations and leukemias induced by inhibitors of topoisomerase II anticarcinogenic drugs].

  1998cited by this paper
• Human keratin-1.bcl-2 transgenic mice aberrantly express keratin 6, exhibit reduced sensitivity to keratinocyte cell death induction, and are susceptible to skin tumor formation

  1998cited by this paper
• Ultraviolet B-radiation dose influences the induction of apoptosis and p53 in human keratinocytes.

  1997cited by this paper
• Regulation of Bcl-xL expression in human keratinocytes by cell-substratum adhesion and the epidermal growth factor receptor.

  1997influential reference
• Signals through gp130 upregulate bcl-x gene expression via STAT1-binding cis-element in cardiac myocytes.

  1997cited by this paper
• Immunohistochemical analysis of Bcl-2, Bcl-X, Mcl-1, and Bax in tumors of central and peripheral nervous system origin.

  1997cited by this paper
• Identification and characterization of second-generation antisense oligonucleotides.

  1997cited by this paper
• Promise and problems of Bcl-2 antisense therapy.

  1997cited by this paper
• Expression of Bcl‐2 and Bax in cultured normal human keratinocytes and melanocytes: relationship to differentiation and melanogenesis

  1997cited by this paper
• BCL-2 antisense therapy in patients with non-Hodgkin lymphoma.

  1997cited by this paper
• Two pathways for induction of apoptosis by ultraviolet radiation in cultured human keratinocytes.

  1997cited by this paper
• Altered mRNA Splicing and Inhibition of Human E-selectin Expression by an Antisense Oligonucleotide in Human Umbilical Vein Endothelial Cells

  1996cited by this paper
• Second-generation antisense oligonucleotides: structure-activity relationships and the design of improved signal-transduction inhibitors.

  1996cited by this paper
• Induction of apoptosis in human HaCaT keratinocytes

  1996cited by this paper
• Molecular thanatopsis: a discourse on the BCL2 family and cell death.

  1996cited by this paper
• Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas.

  1996cited by this paper
• Potent antisense oligonucleotides to the human multidrug resistance-1 mRNA are rationally selected by mapping RNA-accessible sites with oligonucleotide libraries.

  1996cited by this paper
• Over‐expression of bcl‐xL gene in human gastric adenomas and carcinomas

  1996cited by this paper
• Cancer statistics, 1996

  1996cited by this paper
• Altered mRNA Splicing and Inhibition of Human E-selectin Expression by an Antisense Oligonucleotide in Human Umbilical Vein Endothelial Cells*

  1996cited by this paper
• Repair of thalassemic human beta-globin mRNA in mammalian cells by antisense oligonucleotides.

  1996cited by this paper
• Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice

  1995cited by this paper
• Stopped for repairs.

  1995cited by this paper
• Cancer progression and p53.

  1995cited by this paper
• Tumour suppressors, kinases and clamps: How p53 regulates the cell cycle in response to DNA damage

  1995cited by this paper
• Checkpoints of dueling dimers foil death wishes.

  1994cited by this paper
• Cancer. Sun protection factor p53.

  1994cited by this paper
• Sun protection factor p53

  1994cited by this paper
• Immunohistochemical analysis of in vivo patterns of Bcl-X expression.

  1994cited by this paper
• Suppression of apoptosis in a cytotoxic T-cell line by interleukin 2-mediated gene transcription and deregulated expression of the protooncogene bcl-2.

  1993cited by this paper
• Apoptosis of lung cancer cells caused by some anti-cancer agents (MMC, CPT-11, ADM) is inhibited by bcl-2.

  1993cited by this paper
• Constitutive expression of human Bcl-2 modulates nitrogen mustard and camptothecin induced apoptosis.

  1993cited by this paper
• The proto-oncogene bcl-2 can selectively rescue neurotrophic factor-dependent neurons from apoptosis.

  1993cited by this paper
• Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair.

  1993cited by this paper
• A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma.

  1991cited by this paper
• bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship.

  1991cited by this paper
• bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes.

  1991cited by this paper
• Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18)

  1991cited by this paper
• BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death.

  1991cited by this paper
• Basic Radiobiology

  1988cited by this paper
• Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells

  1988cited by this paper

• NAD-Mediated Protection by Nicotinamide Against UVB-Induced Oxidative Damage in HaCaT Cells

  2026cites this paper
• The Protective Effects of Sodium Pentaborate Tetrahydrate Against UVB-induced Apoptosis in Human Keratinocytes

  2022cites this paper
• Endogenous and imposed determinants of apoptotic vulnerabilities in cancer.

  2022cites this paper
• Antioxidant Activities and Protective Effects of Dendropachol, a New Bisbibenzyl Compound from Dendrobium pachyglossum, on Hydrogen Peroxide-Induced Oxidative Stress in HaCaT Keratinocytes

  2021cites this paper
• Study of genetic variants in chromosome 5p15.33 region in non-smoker lung cancer patients.

  2020cites this paper
• Breast cancer: current developments in molecular approaches to diagnosis and treatment.

  2014cites this paper
• CİSPLATİN DİRENCİNDE ETKİLİ MOLEKÜLER MEKANİZMALAR

  2013cites this paper
• The small molecule Retro-1 enhances the pharmacological actions of antisense and splice switching oligonucleotides

  2013cites this paper
• Melanoma and Other Skin Cancers

  2012cites this paper
• Bcl-2 family members: essential players in skin cancer.

  2012cites this paper
• Functional Characterization of CLPTM1L as a Lung Cancer Risk Candidate Gene in the 5p15.33 Locus

  2012cites this paper
• Alternative Splicing in Leukemic Cells and Resensitizes Bcr-Abl T 315 I Mutant Cells to Imatinib

  2011cites this paper
• Amiloride modulates alternative splicing in leukemic cells and resensitizes Bcr-AblT315I mutant cells to imatinib.

  2011cites this paper
• Small‐interfering RNA targeted at antiapoptotic mRNA increases keratinocyte sensitivity to apoptosis

  2011cites this paper
• Introduction of a dermatophyte polymerase chain reaction assay to the diagnostic mycology service in Scotland

  2011cites this paper
• Immunoexpression of Bcl‐x in squamous cell carcinoma and keratoacanthoma: differences in pattern and correlation with pathobiology

  2009cites this paper
• UV‐induced squamous cell carcinoma – a role for antiapoptotic signalling pathways

  2009cites this paper
• Targeted disruption of Bcl‐xL in mouse keratinocytes inhibits both UVB‐ and chemically induced skin carcinogenesis

  2009cites this paper
• Antagonistic Effects of the SRp30c Protein and Cryptic 5 ′ Splice Sites on the Alternative Splicing of the Apoptotic Regulator Bcl-x*

  2008cites this paper
• Antisense oligonucleotides: target validation and development of systemically delivered therapeutic nanoparticles.

  2007cites this paper
• DeltaNp63alpha promotes apoptosis of human epidermal keratinocytes.

  2007cites this paper
• Inhibition of γ ray-induced apoptosis by stimulatory heterotrimeric GTP binding protein involves Bcl-xL down-regulation in SH-SY5Y human neuroblastoma cells

  2007cites this paper
• Targeting Bcl‐XL for prevention and therapy of skin cancer

  2007cites this paper
• Curcumin induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by modulating akt and p38 mAPK

  2007cites this paper
• Expression of Bcl-2 family proteins in psoriasis.

  2007cites this paper
• DNp63a Promotes Apoptosis of Human Epidermal

  2007cites this paper
• Inhibition of gamma ray-induced apoptosis by stimulatory heterotrimeric GTP binding protein involves Bcl-xL down-regulation in SH-SY5Y human neuroblastoma cells.

  2007cites this paper
• Distinct promoters mediate constitutive and inducible Bcl-XL expression in malignant lymphocytes

  2007cites this paper
• ΔNp63α Promotes Apoptosis of Human Epidermal Keratinocytes

  2007cites this paper
• Serpin squamous cell carcinoma antigen inhibits UV-induced apoptosis via suppression of c-JUN NH2-terminal kinase

  2006cites this paper
• Bcl-xL and bcl-2 proteins in melanoma progression and UVB-induced apoptosis.

  2006cites this paper
• Current approaches to cutaneous gene therapy

  2006cites this paper
• Modulation of 5' splice site selection using tailed oligonucleotides carrying splicing signals

  2006cites this paper
• Cell Engineering

  2005cites this paper
• Ultraviolet radiation-induced apoptosis in keratinocytes: on the role of cytosolic factors.

  2005cites this paper
• Heterogeneous Nuclear Ribonucleoprotein F/H Proteins Modulate the Alternative Splicing of the Apoptotic Mediator Bcl-x*

  2005cites this paper
• The dark side of light: the damaging effects of UV rays and the protective efforts of MAP kinase signaling in the epidermis.

  2004cites this paper
• Molecular basis of cellular response to cisplatin chemotherapy in non-small cell lung cancer (Review).

  2004cites this paper
• Antisense oligonucleotides directed at the bcl-xl gene product augment chemotherapy response in mesothelioma.

  2004cites this paper
• Use of Antisense Oligonucleotides in Functional Genomics and Target Validation

  2004cites this paper
• Therapeutic Small Molecule Inhibitors of Bcl-2

  2004cites this paper
• Potential roles of antisense therapy in the molecular targeting of genes involved in cancer (review).

  2004cites this paper
• Resistance to chemotherapy-induced apoptosis via decreased caspase-3 activity and overexpression of antiapoptotic proteins in ovarian cancer

  2004cites this paper
• Modification of Alternative Splicing by Antisense Therapeutics

  2004cites this paper
• Up-regulation of Bfl-1/A1 via NF-kappaB activation in cisplatin-resistant human bladder cancer cell line.

  2004cites this paper
• Bcl-2-targeted cancer therapeutics

  2004cites this paper
• Ultraviolet A-induced Modulation of Bcl-XL by p38 MAPK in Human Keratinocytes

  2004cites this paper
• Down-regulation of protein kinase Ceta by antisense oligonucleotides sensitises A549 lung cancer cells to vincristine and paclitaxel.

  2004cites this paper
• Down‐regulation of Bcl‐2 and Bcl‐xL expression with bispecific antisense treatment in glioblastoma cell lines induce cell death

  2003cites this paper
• Therapeutic activation of caspases in cancer: a question of selectivity.

  2003cites this paper
• Examination of Bcl‐2, Bcl‐X and bax protein expression in psoriasis

  2003cites this paper
• Premature keratinocyte death and expression of marker proteins of apoptosis in human skin after UVB exposure

  2003cites this paper
• Bcl-xL antisense oligonucleotides radiosensitise colon cancer cells

  2003cites this paper
• Antisense oligonucleotide-based therapeutics for cancer

  2003cites this paper
• In vivo cooperation between Bcl‐xL and the phosphoinositide 3‐kinase‐Akt signaling pathway for the protection of epidermal keratinocytes from apoptosis

  2003influential citation
• Efficient Reduction of Target RNAs by Small Interfering RNA and RNase H-dependent Antisense Agents

  2003cites this paper
• Sensitization of head and neck squamous cell carcinoma cells to Fas-mediated apoptosis by the inhibition of Bcl-X(L) expression.

  2003cites this paper
• Antisense Oligonucleotide Inhibition of Bcl-xL and Bid Expression in Liver Regulates Responses in a Mouse Model of Fas-Induced Fulminant Hepatitis

  2003influential citation
• Exploring Alternative Transcript Structure in the Humangenome Using Blocks and Interpro

  2003cites this paper
• In vivo cooperation between Bcl-XL and the phosphoinositide 3-kinase-Akt signaling pathway for the protection of epidermal keratinocytes from apoptosis

  2003cites this paper
• Activation of Caspase-9 Is Required for UV-induced Apoptosis of Human Keratinocytes*

  2002cites this paper
• Gene expressions in Jurkat cells poisoned by a sulphur mustard vesicant and the induction of apoptosis

  2002cites this paper
• Antisense RNA down-regulation of bcl-xL Expression in prostate cancer cells leads to diminished rates of cellular proliferation and resistance to cytotoxic chemotherapeutic agents.

  2002cites this paper
• Antisense strategy shows that Mcl-1 rather than Bcl-2 or Bcl-x(L) is an essential survival protein of human myeloma cells.

  2002cites this paper
• Bcl‐XL is a chemoresistance factor in human melanoma cells that can be inhibited by antisense therapy

  2002cites this paper
• Cellular Response to an Antisense-mediated Shift of Bcl-x Pre-mRNA Splicing and Antineoplastic Agents*

  2002cites this paper
• Bcl-xL deamidation is a critical switch in the regulation of the response to DNA damage.

  2002cites this paper
• Selective peroxidation and externalization of phosphatidylserine in normal human epidermal keratinocytes during oxidative stress induced by cumene hydroperoxide.

  2002cites this paper
• Bcl-xL Antisense Oligonucleotides Chemosensitize Human Glioblastoma Cells

  2002cites this paper
• Inhibition of Bcl-xL expression sensitizes T-cell acute lymphoblastic leukemia cells to chemotherapeutic drugs.

  2002cites this paper
• HPV-16 E6/7 Immortalization Sensitizes Human Keratinocytes to Ultraviolet B by Altering the Pathway from Caspase-8 to Caspase-9-dependent Apoptosis*

  2002cites this paper
• Antisense therapy: recent advances and relevance to prostate cancer.

  2002cites this paper
• Efficiency of Antisense Oligonucleotide Drug Discovery

  2002cites this paper
• Bcl-2-related proteins, alpha-smooth muscle actin and amyloid deposits in aggressive and non-aggressive basal cell carcinomas.

  2002cites this paper
• Modification of alternative splicing by antisense oligonucleotides as a potential chemotherapy for cancer and other diseases.

  2001cites this paper
• Keratinocyte apoptosis induced by ultraviolet B radiation and CD95 ligation -- differential protection through epidermal growth factor receptor activation and Bcl-x(L) expression.

  2001cites this paper
• In vivo suppression of Bcl‐XL expression facilitates chemotherapy‐induced leukaemia cell death in a SCID/NOD‐Hu model

  2001cites this paper
• Antisense oligonucleotides as research tools.

  2001cites this paper
• Antisense oligonucleotides in cutaneous therapy.

  2001cites this paper
• Mechanisms of resistance to cisplatin.

  2001cites this paper
• Antisense oligonucleotides: promise and reality.

  2001cites this paper
• In Vitro and In Vivo Transfer of bcl-2 Gene into Keratinocytes Suppresses UVB-induced Apoptosis¶

  2001cites this paper
• Functional genomics and target validation approaches using antisense oligonucleotide technology.

  2001cites this paper
• Effect of low-dose irradiation on induction of an apoptotic adaptive response in the murine system

  2001cites this paper
• Constitutively activated Stat3 protects fibroblasts from serum withdrawal and UV-induced apoptosis and antagonizes the proapoptotic effects of activated Stat1.

  2001cites this paper
• Ultraviolet irradiation activates PI 3-kinase/AKT survival pathway via EGF receptors in human skin in vivo.

  2001cites this paper
• The expression of antiapoptotic proteins Bcl-2, Bcl-X(L), and Mcl-1 in benign, dysplastic, and malignant biliary epithelium.

  2001cites this paper
• In Vitro and In Vivo Transfer of bcl‐2 Gene into Keratinocytes Suppresses UVB‐induced Apoptosis ¶

  2001cites this paper
• Mechanisms of JP-8 jet fuel cell toxicity. II. Induction of necrosis in skin fibroblasts and keratinocytes and modulation of levels of Bcl-2 family members.

  2001cites this paper
• Potential therapeutic application of antisense oligonucleotides in the treatment of ocular diseases

  2001cites this paper
• Chemosensitization of bladder carcinoma cells by bcl-xL antisense oligonucleotides.

  2001cites this paper
• ANTISENSE OLIGONUCLEOTIDES: Promise

  2001cites this paper
• Modification of Alternative Splicing of Bcl-x Pre-mRNA in Prostate and Breast Cancer Cells

  2001cites this paper
• Melanoma Techniques and Protocols

  2001cites this paper
• Bcl‐XL Antisense Sensitizes Human Colon Cancer Cell Line to 5‐Fluorouracil

  2000cites this paper
• Activated ras Prevents Downregulation of Bcl-XL Triggered by Detachment from the Extracellular Matrix

  2000cites this paper
• Resistance to apoptosis is correlated with the reduced caspase-3 activation and enhanced expression of antiapoptotic proteins in human cervical multidrug-resistant cells.

  2000cites this paper
• Antisense Downregulation of the Apoptosis-related Bcl-2 and Bcl-xL Proteins: A New Approach to Cancer Therapy

  2000cites this paper
• Bcl-xL in prostate cancer cells: effects of overexpression and down-regulation on chemosensitivity.

  2000cites this paper
• The induction of apoptosis and inhibition of AP-1 activity by TAC-101 (4-[3,5-bis(trimethylsilyl) benzamido] benzoic acid) may result in life prolonging effect in animals bearing metastasizing cancer.

  2000cites this paper